US Patent Issued to Cellenkos on Nov. 18 for "Compositions comprising regulatory t cells and methods of making and using the same" (Texas Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,182, issued on Nov. 18, was assigned to Cellenkos Inc. (Houston).

"Compositions comprising regulatory t cells and methods of making and using the same" was invented by Simrit Parmar (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are populations of ex vivo expanded umbilical cord blood-derived regulatory T cells. Also provided are methods of making and using the same."

The patent was filed on Sept. 25, 2020, under Application No. 17/032,831.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html...